HPLC Method for Analysis of Valsartan

Chr_1051




Valsartan is a nonpeptide triazole-derived antagonist of angiotensin that selectively and competitively blocks the binding of angiotensin II to the AT1 subtype receptor. It is used to treat high blood pressure and heart failure, as well as to improve the chance of someone living longer after a heart attack. Primesep 200, a reverse phase column, contains embedded acidic ionizable groups and can retain Valsartan. The method is UV compatible and can be used as a general approach for analyzing similar compounds.

Application Column

Primesep 200

The Primesep family of mixed-mode columns offers a wide variety of stationary phases, boasting unprecedented selectivity in the separation of a broad array of chemical compounds across multiple applications. Corresponding Primesep guard columns, available with all stationary phases, do not require holders. SIELC provides a method development service available to all customers. Inquire about our specially-tailored custom LC-phases for specific separations.

Select options
Application Analytes:
Valsartan

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.